MediXall (MDXL) Retained Earnings (2019 - 2024)
MediXall's Retained Earnings history spans 8 years, with the latest figure at -$39.0 million for Q3 2024.
- For Q3 2024, Retained Earnings fell 9.16% year-over-year to -$39.0 million; the TTM value through Sep 2024 reached -$39.0 million, down 9.16%, while the annual FY2023 figure was -$37.2 million, 13.99% down from the prior year.
- Retained Earnings reached -$39.0 million in Q3 2024 per MDXL's latest filing, down from -$38.1 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$19.6 million in Q4 2020 to a low of -$39.0 million in Q3 2024.
- Average Retained Earnings over 5 years is -$30.7 million, with a median of -$31.7 million recorded in 2022.
- Peak YoY movement for Retained Earnings: tumbled 43.46% in 2020, then fell 9.16% in 2024.
- A 5-year view of Retained Earnings shows it stood at -$19.6 million in 2020, then tumbled by 31.66% to -$25.8 million in 2021, then decreased by 26.49% to -$32.6 million in 2022, then fell by 13.99% to -$37.2 million in 2023, then dropped by 4.88% to -$39.0 million in 2024.
- Per Business Quant, the three most recent readings for MDXL's Retained Earnings are -$39.0 million (Q3 2024), -$38.1 million (Q2 2024), and -$37.7 million (Q1 2024).